Cell chemical biology

Elsevier BV

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Cell chemical biology is a journal published by Elsevier BV in Netherlands. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 9,080 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier BV
ISSN
2451-9456 · 2451-9448
Country
Netherlands
Access
Not open access / not declared
Declared publication charge
9,080 USD
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2016-01-01
  • PUBMED · 2016-01-21
Indexing
MEDLINE · PUBMED
APC
9,080 USD
Declared review time (DOAJ)
—
Actual review time (measured)
176 days received→accepted — computed from PubMed (n=99)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

1805

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

117

i10-index

1180

From OpenAlex open data (CC0).

Editorial & policy4
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
91%
ORCID iDs in current deposits
57%
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101676030
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Ubiquitin and proteasome pathways
  • Ubiquitin and proteasome pathways
  • Protein Degradation and Inhibitors
  • Protein Degradation and Inhibitors
  • RNA and protein synthesis mechanisms
  • RNA and protein synthesis mechanisms
  • RNA modifications and cancer
  • RNA modifications and cancer
Show all subjects (50)
  • Peptidase Inhibition and Analysis
  • Peptidase Inhibition and Analysis
  • Click Chemistry and Applications
  • Click Chemistry and Applications
  • Monoclonal and Polyclonal Antibodies Research
  • Monoclonal and Polyclonal Antibodies Research
  • Microbial Natural Products and Biosynthesis
  • RNA Research and Splicing
  • Microbial Natural Products and Biosynthesis
  • RNA Research and Splicing
  • CRISPR and Genetic Engineering
  • CRISPR and Genetic Engineering
  • Glycosylation and Glycoproteins Research
  • Endoplasmic Reticulum Stress and Disease
  • Endoplasmic Reticulum Stress and Disease
  • Glycosylation and Glycoproteins Research
  • Biochemical and Molecular Research
  • Biochemical and Molecular Research
  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • Advanced biosensing and bioanalysis techniques
  • Advanced biosensing and bioanalysis techniques
  • Autophagy in Disease and Therapy
  • Autophagy in Disease and Therapy
  • Chemical Synthesis and Analysis
  • Chemical Synthesis and Analysis
  • Bacterial Genetics and Biotechnology
  • Bacterial Genetics and Biotechnology
  • Histone Deacetylase Inhibitors Research
  • Epigenetics and DNA Methylation
  • Epigenetics and DNA Methylation
  • Histone Deacetylase Inhibitors Research
  • Receptor Mechanisms and Signaling
  • Mitochondrial Function and Pathology
  • Receptor Mechanisms and Signaling
  • Cancer, Hypoxia, and Metabolism
  • Mitochondrial Function and Pathology
  • Cancer, Hypoxia, and Metabolism
  • RNA Interference and Gene Delivery
  • RNA Interference and Gene Delivery
  • Ferroptosis and cancer prognosis
  • Ferroptosis and cancer prognosis

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: